According to the chief surgeon of the Armed Forces of Ukraine, colonel of the medical service Kostyantyn Humenyuk, the main cause of death on the battlefield is bleeding.
If a large artery is damaged, the injured person often dies before receiving help. Severe bleeding from arms or legs can kill within minutes, and a tourniquet is often the fastest way to control it.
Tourniquets are widely regarded as lifesaving in both battlefield and civilian emergency medicine, but users struggle to use them correctly.
Norwegian startup Aristeia is developing a next-generation emergency tourniquet designed to make it faster, easier, and less painful to stop life-threatening bleeding for both professional first responders and non-medical users.
On my trip to Kyiv earlier this year, I sat down with Aristeia founders Gard Fostad Moe (CEO) and Hsin Chen (COO) to learn all about it.
